Approach

Heart disease is the largest single cause of mortality throughout the European Union. Patients presenting at the emergency department of a hospital with symptoms that may indicate a recent heart attack, require immediate diagnostic evaluation and care, in order to save as much cardiac tissue as possible.  Both the electrocardiogram (ECG) and blood testing/assay are important elements of the diagnostic puzzle in determining whether there is evidence of cardiac damage. With the ECG often being inconclusive, the level of the Troponin cardiac biomarker in the blood provides the physician with vital information for treatment. The current standard procedure for blood tests is the taking of a sample, which is then sent to a clinical laboratory for testing by trained lab-professionals. There is generally a delay of one, up to two hours before the results are reported back to the physician. This relatively long turnaround time can delay treatment and lead to sub-optimal patient management.

The system under investigation can detect the cardiac cTnI biomarker at the Point-of-Care (POC). Blood samples can be taken and tested directly by the physician, nurse or paramedic and the system will provide a quantitative cTnI measurement result within 10 minutes, rather than having to wait for laboratory results. This solution will enable much quicker treatment decisions, optimizing patient outcome and reducing the integral treatment (healthcare) costs. In addition, a quick test result can help to safely rule out a heart attack earlier for those patients suffering from a different illness, contributing to reduction of Emergency Department overcrowding and freeing up healthcare resources.

The Lab 2 Go project is a European Union funded Research and Development project being conducted at six hospitals in the European Union (Austria, France, Germany, Netherlands, United Kingdom) and supported by a number of European based companies working together to develop and prepare this cTnI test for industrialization.

The study is designed to allow the measuring of the analytical and clinical performance of the system operated by the intended users in the intended use environment. In addition user feedback on the usability of the system in the Emergency Department is being gathered. Furthermore various elements of the service & support chain are being tested and evaluated.

Minicare I-20 load cartridge - CloseUp

The study is designed to allow the measuring of the analytical and clinical performance of the system operated by the intended users in the intended use environment. In addition user feedback on the usability of the system in the Emergency Department is being gathered. Furthermore various elements of the service & support chain are being tested and evaluated.